Wave Life Sciences GAAP EPS of -$0.30 beats by $0.03, revenue of $13.16M beats by $8.77M
- Wave Life Sciences press release (WVE): Q3 GAAP EPS of -$0.30 beats by $0.03.
- Revenue of $13.16M (+72.9% Y/Y) beats by $8.77M.
- Well capitalized with cash, cash equivalents, and marketable securities of $431.0 million as of September 30, 2026; additional $12 million milestone from GSK to
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.